Peptides Market Projected to Exceed US$ 89.6 Bn by 2033 Driven by Advancement in Peptide Synthesis | Marketresearch.biz
January 29, 2024 02:03 ET
|
MarketResearch.biz
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The peptides market was valued at USD 45.5 billion in 2023 with significant growth and is projected to reach at USD 89.6 billion by 2033 with an...
Workplace Weight Loss & Wellness Program Unveiled
October 04, 2023 13:27 ET
|
Telegenixx
Telegenix's New Program Enables Employers to Provide Access to Pharma-Assisted Weight Loss at a Cost of $299 per Month, 70% Below the Industry Average
Hofseth Biocare ASA: SUCCESSFULLY COMPLETED SEED ROUND CAPITAL RAISE IN HBC IMMUNOLOGY LLC AT $20M VALUATION FOR THE DEVELOPMENT OF A NEW PROSTATE CANCER CO-THERAPY
August 17, 2023 02:58 ET
|
Hofseth Biocare ASA
HBC Immunology LLC (“HBCI” or the “Company”), a majority owned subsidiary of Hofseth BioCare ASA (“HBC”), has successfully completed the required minimum seed capital financing of approx. USD 900,000...
Growing Emphasis on Generic Drug Manufacturing Boosts Active Pharmaceutical Ingredient Market to US$ 300.2 Billion by 2033: Persistence Market Research
July 25, 2023 14:33 ET
|
Persistence Market Research
New York, July 25, 2023 (GLOBE NEWSWIRE) -- Worldwide revenue from the active pharmaceutical ingredients market stands at US$ 192.3 Billion in 2022, with the global market estimated to surge ahead...
Size Report: Cosmeceuticals Market to Reach $81.75 Billion by 2028 with Skin Care Segment Driving Growth during 2021-2028 | The Insight Partners
July 11, 2023 09:46 ET
|
The Insight Partners
Pune, India, July 11, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Cosmeceuticals Market Size Report, Share, Revenue, Growth Strategy, Industry Trends and...
IRBM Extends Peptide Therapeutics Collaboration with Merck & Co. Inc., Rahway NJ USA
June 22, 2023 16:30 ET
|
IRBM
ROME, June 22, 2023 (GLOBE NEWSWIRE) -- IRBM, an innovative contract research organization, today announced it has signed a new agreement with Merck & Co. Inc., Rahway NJ USA, known as MSD...
Hofseth Biocare ASA: SPIN-OFF OF PROSTATE CANCER CO-TREATMENT PROJECT
May 15, 2023 01:50 ET
|
Hofseth Biocare ASA
Hofseth Biocare ASA ("HBC" or the "Company") today announces the decision to transfer its prostate cancer co-treatment project (the "Project") to a new US entity to be called HBC Immunology Inc....
Vestaron Launching Spear® RC Product
February 24, 2023 09:26 ET
|
Vestaron
RTP, North Carolina, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Vestaron, a leading producer of peptide-based bioinsecticides, has launched its latest addition in the Spear family of products, Spear® RC....
Vestaron Joins Leading Harvest as Program Supporter
February 14, 2023 10:57 ET
|
Vestaron
RTP, North Carolina, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Vestaron, a leading producer of peptide-based bioinsecticides is proud to announce its membership as a Program Supporter of Leading Harvest, an...
Sarah Fox Joins Vestaron as VP, Sustainability
January 31, 2023 10:00 ET
|
Vestaron
RTP, North Carolina, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Vestaron Corporation, the leading producer of peptide-based bio-pesticides, announced the appointment of Sarah Fox as its first Vice President...